You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Under the agreements, Bioké, a business unit of Cell Signaling Technology Europe, will distribute the two platforms in the Netherlands, Belgium, and Luxembourg.
Using single-cell and bulk RNA sequence data, investigators identified four pathway-based GBM subtypes, including a mitochondrial subtype that appears to respond to related inhibitors.
The method, published in Science, pairs in situ sequencing with NGS using barcodes to provide spatial information on DNA sequences inside tissues.
Investigators saw enhanced interleukin-13 production by a handful of immune cell types in mouse models of steroid-resistant asthma.
Evorion also closed a financing round for an undisclosed amount, and Jüke has become a shareholder in the company.